Product
JMKX003142
Aliases
JMKX003142 will be administered orally
2 clinical trials
2 indications
Indication
Healthy AdultIndication
Safety and TolerabilityClinical trial
Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003142 Injection Administered Randomly, Double-blind, Placebo-controlled, Single-ascending Dose and Multiple-ascending Doses in Chinese Healthy Adult SubjectsStatus: Not yet recruiting, Estimated PCD: 2025-01-31
Clinical trial
Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003142 Tablets Administered Randomly, Double-blind, Placebo-controlled Single and Multiple Times in Healthy Adult Subjects, as Well as the Effects of Randomized, Open, and Two Cycle Crossover FoodsStatus: Recruiting, Estimated PCD: 2024-07-31